| Entry |
|
| Name |
EGF-overexpression to PI3K signaling pathway
|
| Definition |
EGF* -> EGFR -> PI3K -> PIP3 -> AKT |
| Expanded |
1950v1 -> 1956 -> (5290,5291,5293) -> C05981 -> (207,208,10000) |
| Class |
|
| Type |
Variant
|
| Pathway |
|
| Disease |
|
| Gene |
| 1950 | EGF; epidermal growth factor |
| 1956 | EGFR; epidermal growth factor receptor |
| 5290 | PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| 5291 | PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
| 5293 | PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
| 207 | AKT1; AKT serine/threonine kinase 1 |
| 208 | AKT2; AKT serine/threonine kinase 2 |
| 10000 | AKT3; AKT serine/threonine kinase 3 |
|
| Variant |
1950v1 (EGF*) EGF overexpression
|
| Metabolite |
| C05981 | Phosphatidylinositol-3,4,5-trisphosphate |
|
| Reference |
|
| Authors |
Wang D, Xia D, Dubois RN |
| Title |
The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer. |
| Journal |
|
| LinkDB |
|